1. Gastric cancer with choriocarcinoma and yolk sac tumor components: case report.
- Author
-
Satake N, Chikakiyo M, Yagi T, Suzuki Y, and Hirose T
- Subjects
- Adenocarcinoma metabolism, Adenocarcinoma therapy, Aged, Antimetabolites, Antineoplastic therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor metabolism, Carcinoembryonic Antigen metabolism, Choriocarcinoma metabolism, Choriocarcinoma therapy, Chorionic Gonadotropin, beta Subunit, Human metabolism, Cisplatin therapeutic use, Disease-Free Survival, Drug Combinations, Endodermal Sinus Tumor metabolism, Endodermal Sinus Tumor therapy, Humans, Male, Neoplasms, Multiple Primary, Oxonic Acid therapeutic use, Radiotherapy, Adjuvant, Stomach Neoplasms metabolism, Stomach Neoplasms therapy, Tegafur therapeutic use, alpha-Fetoproteins metabolism, Adenocarcinoma secondary, Choriocarcinoma secondary, Endodermal Sinus Tumor secondary, Stomach Neoplasms pathology
- Abstract
Choriocarcinoma- and yolk sac tumor-like differentiation have rarely been reported in gastric cancers. We report a case of gastric adenocarcinoma, concurrently possessing choriocarcinoma and yolk sac tumor components, of a 74-year-old man. A hemorrhagic, 11 × 8 × 3 cm, tumor with ulceration was located in the body and pre-pylorus of the stomach. Histological examination of the resected specimens demonstrated intermingled proliferation of three different components, namely, adenocarcinoma, choriocarcinoma and yolk sac tumor, which were immunoreactive for carcinoembryonic antigen (CEA), beta-subunit of human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP), respectively. Gastric cancers with germ cell tumor components are uncommon and this is the second reported case of gastric cancer with choriocarcinoma and yolk sac tumor components., (© 2011 The Authors. Pathology International © 2011 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd.)
- Published
- 2011
- Full Text
- View/download PDF